Lexicon Pharmaceuticals, Inc. (LXRX)
NASDAQ: LXRX · Real-Time Price · USD
1.500
0.00 (0.00%)
At close: Feb 26, 2026, 4:00 PM EST
1.548
+0.048 (3.22%)
After-hours: Feb 26, 2026, 6:30 PM EST
Revenue by Segment
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|
| Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 | Dec '15 Dec 31, 2015 |
|---|
Discovery, Development and Commercialization of Pharmaceutical Products | 31.08M | 1.20M | 139.00K | 298.00K | 24.00M | | | | | |
Discovery, Development and Commercialization of Pharmaceutical Products Growth | 2481.48% | 766.19% | -53.36% | -98.76% | -92.55% | | | | | |
| 31.08M | 1.20M | 139.00K | 298.00K | 24.00M | | | | | |
| 2481.48% | 766.19% | -53.36% | -98.76% | -92.55% | | | | | |
Revenue by Geography
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|
| Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 | Dec '15 Dec 31, 2015 |
|---|
| 23.52M | | | | | |
| -26.99% | | | | | |
| 479.90K | | | | | |
| 24.00M | | | | | |
| -92.47% | | | | | |
Source: S&P Global Market Intelligence.
